These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 29256353)

  • 1. Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review.
    Pisano S; Pozzi M; Catone G; Scrinzi G; Clementi E; Coppola G; Milone A; Bravaccio C; Santosh P; Masi G
    Curr Neuropharmacol; 2019; 17(4):318-341. PubMed ID: 29256353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
    Bauer M; Adli M; Baethge C; Berghöfer A; Sasse J; Heinz A; Bschor T
    Can J Psychiatry; 2003 Aug; 48(7):440-8. PubMed ID: 12971013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The science and practice of lithium therapy.
    Malhi GS; Tanious M; Das P; Berk M
    Aust N Z J Psychiatry; 2012 Mar; 46(3):192-211. PubMed ID: 22391277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
    Bauer M; Adli M; Bschor T; Pilhatsch M; Pfennig A; Sasse J; Schmid R; Lewitzka U
    Neuropsychobiology; 2010; 62(1):36-42. PubMed ID: 20453533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium: still a cornerstone in the long-term treatment in bipolar disorder?
    Nivoli AM; Murru A; Vieta E
    Neuropsychobiology; 2010; 62(1):27-35. PubMed ID: 20453532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining lithium and anticonvulsants in bipolar disorder: a review.
    Pies R
    Ann Clin Psychiatry; 2002 Dec; 14(4):223-32. PubMed ID: 12630658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single-Blind Randomized Comparison of Lithium and Lamotrigine as Maintenance Treatments for Managing Bipolar II Disorder.
    Parker G; Ricciardi T; Tavella G; Hadzi-Pavlovic D
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):381-388. PubMed ID: 34181361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy with lithium salts in child and adolescent psychiatry--clinical efficacy and practical recommendations].
    Gerlach M; Baving L; Fegert J
    Z Kinder Jugendpsychiatr Psychother; 2006 May; 34(3):181-8; quiz 188-9. PubMed ID: 16771032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.
    Machado-Vieira R; Zanetti MV; Otaduy MC; De Sousa RT; Soeiro-de-Souza MG; Costa AC; Carvalho AF; Leite CC; Busatto GF; Zarate CA; Gattaz WF
    J Clin Psychopharmacol; 2017 Feb; 37(1):40-45. PubMed ID: 27902528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium: clinical considerations in internal medicine.
    Freeman MP; Freeman SA
    Am J Med; 2006 Jun; 119(6):478-81. PubMed ID: 16750958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of lithium for the treatment of acute mania in children with bipolar disorder: A systematic review: A report from the ISBD-IGSLi joint task force on lithium treatment.
    Duffy A; Heffer N; Goodday SM; Weir A; Patten S; Malhi GS; Cipriani A
    Bipolar Disord; 2018 Nov; 20(7):583-593. PubMed ID: 30221434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.